GPP Interview with Professor Barker
An interview with Prof. Barker about generalized pustular psoriasis, its burden on patients and how patient outcomes can be improved
Search
Lady, a guide dog in the office
A great partnership between a Boehringer Ingelheim employee and her guide dog at work. Their relationship goes beyond the human-animal bond.
Combination Therapy
It’s the smart combination of our cancer cell-directed and immuno-oncology approaches that may offer the greatest benefit for people living with cancer.
Prevalence of VTE in the US and Europe.pdf
biotherapeutic_technologies_flyer_bio_05-2020.pdf
Partnering Day France Flyer Save the date 2018 08 02.pdf
biotherapeutic_technologies_flyer_q4_2020.pdf
Biotherapeutic_Technologies_Flyer_BIO_2022.pdf
How AF affects the heart.pdf
The Economic Burden of VTE.pdf
The Global Cardiovascular Disease Burden.pdf
The Global Cardiovascular Disease Burden.pdf
The Economic Burden of VTE.pdf
How AF can affect the heart beat.pdf
How AF can affect the heart beat.pdf
How AF can affect the heart beat.pdf
Praxbind® – the specific reversal agent to dabigatran.pdf
add-on_therapy_Moroni-Zentgraf.pdf
Ivan Blanarik Therapeutic Area Head Respiratory
Ivan Blanarik, Therapeutic Area Head Respiratory at Boehringer Ingelheim
Meet the BD&L Team 2019
Hear from our team and find out more about our approach to partnering.